United States. Eastman Chemical reported earnings from continuing operations of $1.40 per diluted share during the second quarter of 2012, compared to $1.44 in the same period in 2011.
These figures exclude US$33 million from financing, transaction and integration costs in the second quarter of 2012 related to the acquisition of Solutia, and a profit of US$15 million in the second quarter of 2011 from the sale of a previously impaired asset.
Earnings reported from continuing operations were $1.26 per diluted share in the second quarter of 2012 and $1.51 in the second quarter of 2011.
Sales revenue for the second quarter of this year was $1.9 billion, down 2% from the same period a year earlier.
Operating profit was $317 million, $17 million less than in the same quarter of 2011. But excluding transaction and integration costs related to the acquisition of Solutia and a profit from the sale of a previously impaired asset, operating profit was $323 million and $318 million, respectively.
Leave your comment